Dashboard
Manage Tickers

AZTA Azenta, Inc.

Nasdaq azenta.com


$ 30.85 $ -0.53 (-1.68 %)    

Friday, 17-Oct-2025 16:00:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 30.97
$ 31.00
$ 25.00 x 1
$ 37.00 x 18
$ 30.63 - $ 31.49
$ 23.91 - $ 55.64
555,761
na
2.14B
$ 1.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 02-10-2025 12-31-2024 10-Q
4 11-27-2024 09-30-2024 10-K
5 08-06-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-08-2024 12-31-2023 10-Q
8 08-08-2023 06-30-2023 10-Q
9 05-10-2023 03-31-2023 10-Q
10 02-09-2023 12-31-2022 10-Q
11 11-25-2022 09-30-2022 10-K
12 08-09-2022 06-30-2022 10-Q
13 05-16-2022 03-31-2022 10-Q
14 02-09-2022 12-31-2021 10-Q
15 11-24-2021 09-30-2021 10-K
16 08-05-2021 06-30-2021 10-Q
17 05-10-2021 03-31-2021 10-Q
18 02-03-2021 12-31-2020 10-Q
19 11-18-2020 09-30-2020 10-K
20 07-31-2020 06-30-2020 10-Q
21 05-01-2020 03-31-2020 10-Q
22 02-06-2020 12-31-2019 10-Q
23 12-17-2019 09-30-2019 10-K
24 08-02-2019 06-30-2019 10-Q
25 05-03-2019 03-31-2019 10-Q
26 02-08-2019 12-31-2018 10-Q
27 11-29-2018 09-30-2018 10-K
28 08-07-2018 06-30-2018 10-Q
29 05-02-2018 03-31-2018 10-Q
30 02-05-2018 12-31-2017 10-Q
31 11-17-2017 09-30-2017 10-K
32 08-04-2017 06-30-2017 10-Q
33 05-05-2017 03-31-2017 10-Q
34 02-07-2017 12-31-2016 10-Q
35 11-29-2016 09-30-2016 10-K
36 07-28-2016 06-30-2016 10-Q
37 04-28-2016 03-31-2016 10-Q
38 02-03-2016 12-31-2015 10-Q
39 11-05-2015 09-30-2015 10-K
40 08-06-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 21:07:08

raymond-james-upgrades-azenta-to-outperform-announces-35-price-target
Raymond James Upgrades Azenta to Outperfor...
08/06/2025 11:29:49

Raymond James analyst Andrew Cooper upgrades Azenta (NASDAQ:AZTA) from Market Perform to Outperform and announces $35 price ...

evercore-isi-group-maintains-in-line-on-azenta-lowers-price-target-to-33
Evercore ISI Group Maintains In-Line on Az...
08/05/2025 15:19:32

Evercore ISI Group analyst Vijay Kumar maintains Azenta (NASDAQ:AZTA) with a In-Line and lowers the price target from $35 to...

azenta-q3-adj-eps-019-beats-013-estimate-sales-144000m-miss-149227m-estimate
Azenta Q3 Adj. EPS $0.19 Beats $0.13 Estim...
08/05/2025 10:32:29

Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.13 by 43.94...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Core News & Articles
Azenta Joins Frenova And Nephronomics To P...
07/31/2025 20:44:07

Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Ca...

evercore-isi-group-maintains-in-line-on-azenta-raises-price-target-to-35
Evercore ISI Group Maintains In-Line on Az...
07/08/2025 12:47:40

Evercore ISI Group analyst Vijay Kumar maintains Azenta (NASDAQ:AZTA) with a In-Line and raises the price target from $29 to...

azenta-life-sciences-partners-with-form-bio-to-advance-aav-gene-therapy-development
Azenta Life Sciences Partners With Form Bi...
05/13/2025 20:15:08

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patie...

needham-maintains-buy-on-azenta-lowers-price-target-to-40
Needham Maintains Buy on Azenta, Lowers Pr...
05/07/2025 18:46:06

Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and lowers the price target from $59 to $40.

azenta-reaffirms-fy25-organic-revenue-growth-of-3---5
Azenta Reaffirms FY25 Organic Revenue Grow...
05/07/2025 10:36:01

azenta-q2-adj-eps-005-misses-007-estimate-sales-14300m-beat-14091m-estimate
Azenta Q2 Adj. EPS $0.05 Misses $0.07 Esti...
05/07/2025 10:34:50

Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.07 by 28....

Core News & Articles
Earnings Scheduled For May 7, 2025
05/07/2025 08:33:08

insights-ahead-azentas-quarterly-earnings
Insights Ahead: Azenta's Quarterly Earnings
05/06/2025 15:02:16

evercore-isi-group-maintains-in-line-on-azenta-raises-price-target-to-52
Evercore ISI Group Maintains In-Line on Az...
02/06/2025 15:26:51

Evercore ISI Group analyst Vijay Kumar maintains Azenta (NASDAQ:AZTA) with a In-Line and raises the price target from $50 to...

a-glimpse-into-the-expert-outlook-on-azenta-through-4-analysts
A Glimpse Into The Expert Outlook On Azent...
02/06/2025 12:00:43

needham-maintains-buy-on-azenta-raises-price-target-to-59
Needham Maintains Buy on Azenta, Raises Pr...
02/06/2025 10:59:20

Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and raises the price target from $55 to $59.

stocks-rebound-google-eyes-worst-drop-in-a-year-gold-shatters-fresh-records-whats-driving-markets-wednesday
Stocks Rebound, Google Eyes Worst Drop In ...
02/05/2025 19:53:15

Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earn...

azenta-reiterated-fy25-3-5-organic-revenue-growth-and-300-basis-points-adjusted-ebitda-margin-expansion-for-fiscal-2025-excluding-b-medical-systems
Azenta Reiterated FY25 3%-5% Organic Reven...
02/05/2025 12:19:36

Guidance for Continuing Operations for Full Year Fiscal 2025The Company is reiterating its revenue guidance for fiscal year 202...

azenta-q1-2025-adj-eps-008-beats-006-estimate-sales-147510m-beat-146190m-estimate
Azenta Q1 2025 Adj. EPS $0.08 Beats $0.06 ...
02/05/2025 12:03:11

earnings-scheduled-for-february-5-2025
Earnings Scheduled For February 5, 2025
02/05/2025 08:32:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION